C4 Therapeutics, Inc. · NASDAQ:CCCC
Lynx1 Capital Management LP reported a 9.99% stake in C4 Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Lynx1 Capital Management LP reported a 9.99% stake in C4 Therapeutics, Inc., 15,423,691 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 15,423,691
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lynx1 Capital Management LP | 9.99% | 15,423,691 |
| Weston Nichols | 9.99% | 15,423,691 |
Source
Related
- C4 Therapeutics, Inc.
- Lynx1 Capital Management LP
- C4 Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynx1 Capital Management LP · Feb 17, 2026
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026